The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
News|Articles|December 15, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of December 15, 2021
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of today, November 12, 2021, at 3:25 PM, EDT:
• 72.3% of total US population has received at least 1 dose
• 61.1% of total US population is fully vaccinated
• 61.1% of total US population is fully vaccinated
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Vermont: 75.8%
2. Puerto Rico: 75.6%
3. Rhode Island:75.2%
4. Maine: 74.7%
5. Connecticut: 73.9%
2. Puerto Rico: 75.6%
3. Rhode Island:75.2%
4. Maine: 74.7%
5. Connecticut: 73.9%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, December 15, 2021 at 5:22 PM, EDT, there have been:
• 50 216 029 confirmed cases and
• 799 845 deaths
• 799 845 deaths
The 5 states with the highest total confirmed cases are:
1. California: 5 176 154
2. Texas: 4 400 515
3. Florida: 3 754 042
4. New York: 2 868 885
5. Illinois: 1 911 649
2. Texas: 4 400 515
3. Florida: 3 754 042
4. New York: 2 868 885
5. Illinois: 1 911 649
Deaths: California has the highest number of deaths due to COVID-19 with 75 411 reported fatalities, followed by Texas with 74 707 and Florida with 62 073.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 271 360 075 confirmed cases, 5 319 254 deaths, and 8 511 570 591 vaccine doses administered.
Advertisement
Related to this article
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement